Back to top
more

PetMed Express (PETS)

(Delayed Data from NSDQ)

$4.32 USD

4.32
319,576

+0.02 (0.47%)

Updated Jun 18, 2024 03:59 PM ET

After-Market: $4.32 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (73 out of 250)

Industry: Internet - Commerce

Better trading starts here.

Zacks News

Fitbit (FIT) Q4 Loss Greater Than Estimated, Revenues Miss

Fitbit's (FIT) fourth-quarter 2017 results are impacted by weak demand for its fitness products.

    NuVasive (NUVA) Meets Q4 Earnings Estimates, Issues '18 View

    NuVasive (NUVA) gains on continued growth in international business in Q4.

      PetMed (PET) Focuses on Advertising to Boost New Order Sales

      PetMed (PETS) implements several strategies to revitalize top line.

        GoDaddy (GDDY) Beats Earnings & Revenue Estimates in Q4

        GoDaddy (GDDY) reports strong fourth-quarter revenues on the back of growth in customers, new products and contribution from HEG acquisition.

          Ryan McQueeney headshot

          After Wayfair's Earnings Miss, Buy These E-Commerce Stocks Instead

          Shares of Wayfair (W) were down more than 17% in early morning trading Thursday after the e-commerce company posted a wider-than-expected fourth-quarter loss. For investors who would rather focus on e-commerce stocks that have recently posted positive earnings surprises, there are plenty of options elsewhere.

            Ryan McQueeney headshot

            3 Retail Stocks That Crushed Earnings Estimates This Season

            The holiday season has the potential to make or break of retailer's fiscal year. Now that we are on the other side of the bulk of Q4's earnings announcements, we can see that several notable companies performed particularly well.

              Garmin (GRMN) Q4 Earnings Beat Estimates, Issues 2018 View

              Garmin (GRMN) delivers strong fourth-quarter results on the back of solid performance in fitness, marine, outdoor and aviation segments.

                Why Is PetMed Express (PETS) Down 9.8% Since the Last Earnings Report?

                PetMed Express (PETS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                  Ecolab (ECL) Misses Q4 Earnings Estimates, View Impressive

                  Despite strength in Global Industrial and Global Institutional segments, Ecolab (ECL) ended the fourth quarter on an unfavorable note.

                    Medtronic (MDT) Beats on Q3 Earnings, Reiterates FY18 View

                    Medtronic (MDT) rides high on strength in all business segments in Q3.

                      Tirthankar Chakraborty headshot

                      The Zacks Analyst Blog Highlights: Boeing, PetMed, Micron, Healthcare and RH

                      The Zacks Analyst Blog Highlights: Boeing, PetMed, Micron, Healthcare and RH

                        Buy These 4 Retail Growth Stocks to Brave Soft Sales Woes

                        Looking superficially, the numbers do raise concerns but a meticulous approach may help alleviate fears. Analysts cited the slump in retail sales as a temporary hitch after a sturdy holiday season.

                          Tirthankar Chakraborty headshot

                          Inflation Scares Overblown! Grab 5 Growth Stocks Now

                          The rise in consumer price index (CPI), especially on a year-on-year basis, remained sluggish, while the recent wage growth was primarily due to seasonal factors that are not likely to last long.

                            TripAdvisor (TRIP) Q4 Earnings Miss Estimates, Revenues Beat

                            TripAdvisor's (TRIP) fourth-quarter results were impacted by a weak performance in the Hotel business. Also, increasing marketing investments continue to be a concern.

                              Applied Materials (AMAT) Beats on Q1 Earnings and Revenues

                              Applied Materials (AMAT) delivers strong fiscal first-quarter results on the back of demand for chips used in electronic items, differentiated products, new technologies and innovation strategy.

                                Hone in on DuPont Analysis & Pick 5 Top Stocks

                                Do you have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.

                                  Chemed (CHE) Beats on Q4 Earnings & Revenues, Issues View

                                  Chemed (CHE) rides on strong contributions from the Roto-Rooter and VITAS businesses in Q4.

                                    GNC Holdings (GNC) Tops Q4 Earnings, Lags Revenue Estimates

                                    Despite sluggish performance by manufacturing/wholesale segments, GNC Holdings (GNC) witnesses revenue growth in Q4.

                                      DaVita (DVA) Beats Q4 Earnings Estimates, Misses Revenues

                                      Impressive results from Kidney Care business drove DaVita (DVA) in Q4.

                                        Amkor Technology (AMKR) Beats on Q4 Earnings, Revenues

                                        Amkor Technology (AMKR) delivers strong fourth-quarter earnings aided by robust growth in all end markets, primarily auto and mobile communication end markets.

                                          Luminex (LMNX) Beats on Q4 Earnings & Revenues, Issues View

                                          Luminex's (LMNX) favorable tidings at the regulatory front in Q4 buoy optimism.

                                            Bruker (BRKR) Beats on Q4 Earnings & Revenues, Issues View

                                            Bruker (BRKR) registers organic revenue growth on strength in NANO and BEST platforms in Q4.

                                              Hologic (HOLX) Q1 Earnings & Revenues Top, Margins Down

                                              Solid growth at Hologic's (HOLX) Molecular Diagnostics, Breast Health and international business drives the top line in Q1.

                                                Surmodics (SRDX) Beats on Earnings in Q1, Guidance Solid

                                                Solid performance in the In Vitro Diagnostics segment drives Surmodics (SRDX) in first-quarter fiscal 2018.

                                                  Expedia (EXPE) Q4 Earnings Miss Estimates, Revenues Up Y/Y

                                                  Expedia's (EXPE) fourth-quarter results hurt by continuing investments in accelerated supply acquisition and cloud migration.